By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    headphones can create health problems
    The Harmful Health Effects of Using Headphones
    September 24, 2021
    Headache causes
    4 Causes Of Headache You Probably Didn’t Know About
    December 28, 2021
    follow these steps to recover from your injury
    What Steps Should You Take to Recover More Quickly from an Injury?
    April 12, 2022
    Latest News
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
    The Hidden Impact Of Stress On Your Body’s Alignment And Balance
    May 22, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    OTC Drugs Should Qualify as Medical Expense for Tax Purposes
    August 5, 2011
    ACOs
    ACOs and Patient Safety: Dos and Don’ts: Video
    May 15, 2012
    America Has A Health Care Paradox
    September 19, 2012
    Latest News
    Preventing Contamination In Healthcare Facilities Starts With Hygiene
    June 15, 2025
    Strengthening Healthcare Systems Through Clinical and Administrative Career Development
    June 13, 2025
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: What Role Does CDMO Play in Gene and Cell Therapy Contract Manufacturing
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > What Role Does CDMO Play in Gene and Cell Therapy Contract Manufacturing
Technology

What Role Does CDMO Play in Gene and Cell Therapy Contract Manufacturing

John Henning
Last updated: July 13, 2022 7:07 pm
John Henning
Share
6 Min Read
SHARE

It has been a remarkable decade for the biopharmaceutical industry. New biopharmaceuticals and blockbuster medications have been developed one after the other. A business model known as “contract development manufacturing organization (CDMO)” has evolved due to the growing demand for biopharmaceuticals. This company is responsible for the research and manufacturing of pharmaceutical production techniques.

Contents
Coming to Cell TherapyAids in AutomationTechnology Transfer That Is Well-Organized and DocumentedCDMO is CompliantFinal Words

Coming to Cell Therapy

The cell source for CGT products might be either primary or modified. When the number of patients and dosage requirements are limited, or when tailored, autologous medicines are generated, drug developers frequently use primary cell lines. 

It’s common for researchers to employ modified cell lines to target bigger patient groups or manufacture exosomes or viral vectors from the cells. Cell therapy contract manufacturers such as Scorpion Biological Services make sure that the technical, regulatory, access, and licensing considerations are taken care of. There are many advantages to working with CDMOs while developing a cell-based therapeutic (CBT). When it comes to tissue processing, cell banking, or cell line engineering, the CDMO can help.

As CGT cell sources’ regulatory landscape continues to evolve, working with an experienced CDMO early on can be beneficial. Licensing fees may apply to the commercial use of commercially available cell sources and vectors that are commonly used in academic and research contexts. 

More Read

Digital Patient Privacy Loss in EHRs and Other Health IT Systems
Kinect Technology – A Grocery Cart that Can Follow The Wheelchair
The Quantified Self Goes to the Olympics
A New Way to Manage Asthma and COPD
High Quality, Low Cost HealthCare Video Interview Series: Robert Herzog and eCaring

Additionally, primary cell and tissue sources for preclinical development might be quite difficult to obtain. CDMOs might use existing connections with public and private organizations to obtain these resources.

Regardless of where the initial cells come from, they must be extensively characterized throughout preclinical development to determine their quality and identity. Process and assay development programs at CDMOs can be tailored to meet the specific requirements of biological input materials.

Aids in Automation

During clinical trials, manufacturing process stability and scalability are two of the most important considerations for cell therapy manufacturers. Process variability, ease of scaling up, and decreased cycle time are equally important motivators for automating their manufacturing and supply chain processes. For example, a CDMO/CMO with EBR capability that is already a completely automatic facility can assist in achieving these goals.

As a result of the negative impact of Covid-19, cell therapy sponsors have had to put a halt to clinical trials and overcome supply chain obstacles. Both in-house and agreement manufacturers have imposed strict frameworks to ensure the safety of their employees in the manufacturing domain. 

To meet delivery deadlines, manufacturers who had embraced automation quickly rebounded. The four-eyes-principle steps could be drastically reduced because fewer hands were touching the paper or the final assembly, lowering the risk of contamination.

Technology Transfer That Is Well-Organized and Documented

Effective and efficient technology (tech) transfer strategies ensure that processes are successfully transferred to a CDMO’s environment. Tech transfer is a complicated process requiring coordination and communication between CGT developers and the CDMO. Transparency is essential. Knowing what a CDMO requires upfront can help you set clear expectations.

When working with a CDMO, tech transfer is more than just a handover; it starts a long-term partnership. To ensure the smoothest possible transmission of information, it is critical to create a strong, cooperative relationship with the CDMO’s principal contact and maintain quality oversight on an ongoing basis. CGT developers should aim to participate in the tech transfer process throughout to ensure that both companies thoroughly document their goals and developments.

Tech transfer documentation aims to increase the biomanufacturing tech transfer process’s efficacy, efficiency, quality, and compliance. A rigorous, dependable technology transfer approach will go a long way toward ensuring success in technical and business areas.

Tech transfer paperwork is a crucial reference that serves as the foundation for developing standard operating procedures (SOPs). This process and product transfer plan outline key characteristics such as materials, analytical processes, and vital quality qualities (CQAs).

The more explicit the process details are, the more useful this document will ensure a smooth technology transfer. This documentation will be crucial if the CGT team decides to bring a process back in-house for commercial production.

CDMO is Compliant

For all biologics, many of the parameters you listed for CDMO selection are critical: e.g., technical skill and knowledge, quality; timetable; facility availability; cost; and communicative capability. 

For CGT manufacturing, how do the selection criteria change?  On the other hand, technical and regulatory environments in the CGT business are evolving at a rate far greater than that of the more established biologics industry. Due-diligence visits should include a more in-depth discussion of CMO knowledge, particularly viral vectors and cell culture.

Final Words

Cell therapy companies can be incentivized to look for third-party partners who hold technical, manufacturing, and regulatory competence by the pressure they are under to innovate and optimize their manufacturing processes. 

One example of a third-party partner would be cell therapy contract and development manufacturing organizations (CDMOs). Nearly thirty contract manufacturing organizations (CDMOs) that specialize in providing manufacturing and clinical trial support for cell therapy companies can be found today.

Share This Article
Facebook Copy Link Print
Share
By John Henning
John Henning is a nutritionist, freelance writer, and food blogger that provides accessible nutrition info to help people live a healthier life. His unique approach to nutrition emphasizes nutrient-dense, whole foods and healthy habits rather than restrictive diets.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

healthcare facilities
Preventing Contamination In Healthcare Facilities Starts With Hygiene
Global Healthcare Infographics
June 15, 2025
from gut to glow
From Plate to Wellness: How Everyday Foods Nourish Your Body Inside and Out
Dental health Infographics Specialties
June 15, 2025
beyond nutrition
Beyond Nutrition: Everyday Foods That Support Whole-Body Health
Health Infographics
June 15, 2025
Transcranial Magnetic Stimulation (TMS) Therapy
How TMS Therapy Helps with Treatment-Resistant Mental Illness
Mental Health Therapies
June 13, 2025

You Might also Like

Healthcare Predictions for 2013

January 7, 2013
liver disease and elastography
DiagnosticsMedical DevicesMedical InnovationsRadiology

Will Shear Wave Elastography Make an Impact in Liver Disease?

October 15, 2014
siemens healthcare
BusinessHealth ReformPolicy & LawTechnology

RSNA 2013: Obamacare and Manufacturers – A Siemens Perspective

December 4, 2013
Radiology and mHealth
eHealthMobile HealthRadiologySpecialtiesTechnology

Why Should Radiologists Be Mobile-Friendly?

August 9, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?